冠状动脉旁路移植术中免接触大隐静脉桥血管的注册随机试验
免接触组腿部伤口并发症更多。
要点
- 免接触静脉采集未显著降低静脉桥失败或临床事件风险
- 免接触组腿部伤口并发症和远期腿部症状显著增加
- 主要终点事件数低于预期,结果需谨慎解读
核心结论
- 免接触大隐静脉采集在减少静脉桥失败或临床事件方面不优于传统开放采集,但增加腿部伤口并发症。
研究设计与样本
- 注册随机试验,纳入902例接受CABG的患者,随机分配至免接触或传统大隐静脉采集组。
- 平均远端静脉吻合口数为2.0(SD 0.87),主要终点平均随访3.5(SD 0.1)年。
主要发现
- 死亡、心肌梗死或再次血运重建复合终点随访4.4(SD 1.3)年,免接触组57/454(12.6%),传统组44/446(9.9%),HR 1.3(95%CI 0.87-1.93)。
- 3个月腿部伤口并发症:免接触组107/433(24.7%) vs 传统组59/427(13.8%),差异10.9个百分点(95%CI 5.7-16.1)。
- 2年时腿部症状残留:免接触组189/381(49.6%) vs 传统组91/361(25.2%),差异24.4个百分点(95%CI 17.7-31.1)。
临床怎么用
- 传统大隐静脉采集仍可作为CABG静脉桥的标准选择,免接触采集需权衡其增加的腿部伤口并发症风险。
- 主要终点事件数低于预期,对免接触采集的疗效判断应谨慎。
局限性
- 主要终点事件数低于预期,可能影响统计效能和结果解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: No-touch saphenous vein harvesting may enhance graft patency and improve clinical outcomes after coronary artery bypass grafting (CABG). METHODS: In this registry-based, randomized trial, patients undergoing CABG were randomly assigned to no-touch or conventional harvesting. The primary composite outcome was the proportion of patients with occluded/stenosed >50% vein graft on coronary computed tomography angiography, or who underwent percutaneous coronary intervention to a vein graft, or died. Secondary outcomes included clinical outcomes and leg wound complications. RESULTS: A total of 902 patients were enrolled with a mean total number of distal vein anastomoses of 2.0 (SD 0.87). The primary endpoint occurred in 90/454 (19.8%) of patients randomized to no-touch and in 107/446 (24.0%) of patients randomized to the conventional technique [difference, -4.3 percentage points; 95% confidence interval (CI) -10.1-1.6; P = .15] at a mean follow-up time of 3.5 (SD 0.1) years. The composite of death, myocardial infarction, or repeat revascularization at 4.4 (SD 1.3) years occurred in 57/454 (12.6%) and 44/446 (9.9%) in the no-touch and conventional groups, respectively (hazard ratio 1.3; 95% CI, 0.87-1.93). Leg wound complications were more common in patients assigned to no-touch harvesting at 3 months [107/433 (24.7%) vs. 59/427 (13.8%); difference, 10.9 percentage points; 95% CI 5.7-16.1]. At 2 years, 189/381 (49.6%) vs. 91/361 (25.2%) had remaining leg symptoms (difference, 24.4 percentage points; 95% CI 17.7-31.1). CONCLUSIONS: No-touch vein graft harvesting for CABG was not superior to conventional open harvesting in reducing vein graft failure or clinical events after CABG but increased leg wound complications. The primary outcome requires cautious interpretation due to a lower-than-expected number of primary events.
引用
- Thelin S, Modrau IS, Duvernoy O, et al. No-touch vein grafts in coronary artery bypass surgery: a registry-based randomized clinical trial. Eur Heart J. 2025. PMID: 39969129. doi:10.1093/eurheartj/ehaf018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。